A multilocus genotyping assay for candidate markers of cardiovascular disease risk
about
Lipoprotein genotype and conserved pathway for exceptional longevity in humansGenetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fracturesAn application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validationRecurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genesFunctional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levelsEpistatic study reveals two genetic interactions in blood pressure regulation.Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6qSearch for haplotype interactions that influence susceptibility to type 1 diabetes, through use of unphased genotype data.Buffering mechanisms in aging: a systems approach toward uncovering the genetic component of aging.Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis.Effects of interacting networks of cardiovascular risk genes on the risk of type 2 diabetes mellitus (the CODAM study).New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-analysis.Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: datAssociation of congenital cardiovascular malformations with 33 single nucleotide polymorphisms of selected cardiovascular disease-related genesA method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studiesMTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women.Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.Association of CVD candidate gene polymorphisms with ischemic stroke and cerebral hemorrhage in Chinese individualsAngiotensin I-converting enzyme: genotype and disease associations.The predictive power of haplotypes in clinical response.Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT StudyAlanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans.Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis.Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes.Invited review: Identifying new mouse models of cardiovascular disease: a review of high-throughput screens of mutagenized and inbred strains.Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infectionGene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).Genetic polymorphisms and cerebral palsy in very preterm infants.Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women.Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibilityPeroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analysesInterrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular diseaseBrain-derived neurotrophic factor (BDNF) gene: a gender-specific role in cognitive function during normal cognitive aging of the MEMO-Study?Acute and chronic effects of resistance exercise on blood pressure in elderly women and the possible influence of ACE I/D polymorphismPolymorphisms in the renin-angiotensin system and migraine in women
P2860
Q21146060-BB1CB652-8564-4C2D-BB97-2BC3DB3E55C8Q24289507-8074E881-BBA4-4C04-876E-4EFF1ABE776DQ24804221-C5FA321F-5871-4C88-8948-8BC0C9FD6947Q28365985-ED2CD176-C193-49EE-BCC6-6392F5969E65Q28729063-22160150-35A1-4599-833F-F10C2DA33EBFQ30425631-E6049BB6-D7D6-4290-979B-8D6C4CB1BCBBQ30486850-29D8DAB9-91F4-4E0C-B586-DBB62E18BD64Q33195345-68BDDCC2-F0E3-4E58-9DD8-DFC6C092EF56Q33296879-F6185811-C2B8-4CAA-A7F0-EE5487D99BE9Q33318443-14ABB78C-5892-4ACB-97A6-1CF45A4867B1Q33330511-6E201B4E-03E7-4F13-9C5A-495BC756B2BCQ33338981-85A14D64-F7B4-416D-818C-C8ED6A3A96B8Q33346323-25E75557-3D05-4E32-92F9-45A59902A89FQ33424203-4194A825-BA1B-4C7A-BDE0-EFB23F8E2CC0Q33801304-EB4F3B17-4C5E-4738-9179-488B8DE66410Q33904720-29AA0653-BB3C-4617-8660-0CC3EE0FFA8DQ33925703-5E23F95F-4FB9-4466-82F0-3F9EC6B72905Q34024542-F7E287FE-9633-4195-8502-1D085629F505Q34038082-F41092BC-50CC-4E2D-B81C-48673DAFECA5Q34075575-C34735B7-84DE-4C29-8BDC-FE92C8A4B2DBQ34169059-8C6555DD-D87E-4259-8A67-0920D63EFC61Q34189871-B4377928-24B5-4756-9E22-37FBBED4E721Q34212370-6A49AEAC-AD44-453C-B194-8199EAC861DCQ34509923-340EDBBC-1375-43D9-9246-BBDDBF3138DDQ34572419-89C672A5-0905-4F23-B931-C3099D1134C2Q34859942-C773AE7D-84E3-4466-B76F-E3A581DF0340Q34969614-F17D4D35-C5F1-450B-95E8-9F7F363B3069Q35081497-81A26337-23F1-4CC2-8AFD-2C7525D918DBQ35231847-9B68C803-768C-4CFC-9B91-51B7A8C49E8EQ35595865-64C1CDDD-503D-431E-85F8-0E42A5528F54Q35886165-72F30046-3664-42A1-B39A-A7CAF372A835Q35953241-AA2FF4B5-9DC7-4DFB-BEF2-EB0F9FF0CBFAQ36046675-315B4C78-5134-407F-A996-C5C627341D42Q36661117-15CA902E-9CFA-4939-A00A-72C1A902B77CQ36786622-30637016-CF2E-46A4-8F9C-45CB7B332F69Q36812818-E5869CEC-8EF3-47E5-9955-FAC4459E56A1Q36925334-1E8B9138-4144-4B85-B580-2A7CDD154967Q36927469-87E4D5F3-0946-4F6D-9D3B-31B2F3C2F930Q37027518-2AA1EB8A-B0E9-4F4A-9DFA-04D328233D7AQ37102338-AEC6A60C-DEFB-44E8-8A14-B09FB160B0F4
P2860
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
@ast
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
@en
type
label
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
@ast
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
@en
prefLabel
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
@ast
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
@en
P2093
P2860
P356
P1433
P1476
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
@en
P2093
C R Pullinger
H A Erlich
M J Malloy
P2860
P304
P356
10.1101/GR.9.10.936
P577
1999-10-01T00:00:00Z